A translational journey in Germany: From literature to local implementation of [89Zr]Zr-DFO-trastuzumab
{{output}}
Aim: [⁸⁹Zr]Zr-DFO-trastuzumab has emerged as a powerful tool to visualise non-invasively HER2 expression across metastatic lesions, complementing conventional pathological HER2 evaluation and helping to identify patients unlike... ...
